Behavioural activation therapies for depression in adults with non-communicable diseases

Eleonora Uphoff; Malini Pires; Corrado Barbui; Deepa Barua; Rachel Churchill; David Ekers; Edward Fottrell; Papiya Mazumdar; Marianna Purgato; Rusham Rana; Judy Wright; Najma Siddiqi

doi:10.1002/14651858.CD013461

Behavioural activation therapies for depression in adults with non-communicable diseases

Eleonora Uphoff^*, Malini Pires, Corrado Barbui, Deepa Barua, Rachel Churchill, David Ekers, Edward Fottrell, Papiya Mazumdar, Marianna Purgato, Rusham Rana, Judy Wright, Najma Siddiqi

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The primary objective is to examine the effects of behavioural activation compared to any control group for the treatment of depression in adults with non-communicable diseases (NCDs). The secondary objectives is to examine the effects of behavioural activation compared to each control group separately (no treatment, waiting list, other psychological therapy, pharmacological treatment, or any other type of treatment as usual) for the treatment of depression in adults with NCDs.

Original language	English
Article number	CD013461
Journal	Cochrane Database of Systematic Reviews
Volume	2019
Issue number	10
DOIs	https://doi.org/10.1002/14651858.CD013461
Publication status	Published - 29 Oct 2019

Bibliographical note

Publisher Copyright:
© 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Access to Document

10.1002/14651858.CD013461

Cite this

@article{bcc75536a6b64ea6b851af1591b17691,

title = "Behavioural activation therapies for depression in adults with non-communicable diseases",

abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The primary objective is to examine the effects of behavioural activation compared to any control group for the treatment of depression in adults with non-communicable diseases (NCDs). The secondary objectives is to examine the effects of behavioural activation compared to each control group separately (no treatment, waiting list, other psychological therapy, pharmacological treatment, or any other type of treatment as usual) for the treatment of depression in adults with NCDs.",

author = "Eleonora Uphoff and Malini Pires and Corrado Barbui and Deepa Barua and Rachel Churchill and David Ekers and Edward Fottrell and Papiya Mazumdar and Marianna Purgato and Rusham Rana and Judy Wright and Najma Siddiqi",

note = "Publisher Copyright: {\textcopyright} 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.",

year = "2019",

month = oct,

day = "29",

doi = "10.1002/14651858.CD013461",

language = "English",

volume = "2019",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "The Cochrane Collaboration",

number = "10",

}

TY - JOUR

T1 - Behavioural activation therapies for depression in adults with non-communicable diseases

AU - Uphoff, Eleonora

AU - Pires, Malini

AU - Barbui, Corrado

AU - Barua, Deepa

AU - Churchill, Rachel

AU - Ekers, David

AU - Fottrell, Edward

AU - Mazumdar, Papiya

AU - Purgato, Marianna

AU - Rana, Rusham

AU - Wright, Judy

AU - Siddiqi, Najma

PY - 2019/10/29

Y1 - 2019/10/29

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The primary objective is to examine the effects of behavioural activation compared to any control group for the treatment of depression in adults with non-communicable diseases (NCDs). The secondary objectives is to examine the effects of behavioural activation compared to each control group separately (no treatment, waiting list, other psychological therapy, pharmacological treatment, or any other type of treatment as usual) for the treatment of depression in adults with NCDs.

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The primary objective is to examine the effects of behavioural activation compared to any control group for the treatment of depression in adults with non-communicable diseases (NCDs). The secondary objectives is to examine the effects of behavioural activation compared to each control group separately (no treatment, waiting list, other psychological therapy, pharmacological treatment, or any other type of treatment as usual) for the treatment of depression in adults with NCDs.

UR - http://www.scopus.com/inward/record.url?scp=85074330722&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD013461

DO - 10.1002/14651858.CD013461

M3 - Article

AN - SCOPUS:85074330722

SN - 1469-493X

VL - 2019

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 10

M1 - CD013461

ER -

Behavioural activation therapies for depression in adults with non-communicable diseases

Abstract

Bibliographical note

Access to Document

Other files and links

Cite this